Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,641.58
(
0.18%
)
News Focus
News Focus
Post# of 257265
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lumpy9200

Send PM Follow Ignore
Followers 41
Posts 2607
Boards Moderated 0
Alias Born 05/21/2006

lumpy9200

Re: gym gravity post# 48823

Friday, 06/22/2007 6:07:50 AM

Friday, June 22, 2007 6:07:50 AM

Post# of 257265
Amylin/Novo-Nordisk

"We think liraglutide, which is human GLP-1, will emerge as a less potent and less convenient version of LAR,"

My understanding is that Liraglutide does not cause the nausea that is brought on by Byetta for a percentage of users. No nausea might make daily Liraglutide far MORE convenient than weekly injections of Byetta.

Time will tell, I suppose.

Best regards,
Geoff
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today